{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001764013","name":"Immunovant, Inc.","summary":"Immunovant is a clinical-stage immunology company developing IMVT-1402, a fully human monoclonal antibody inhibiting the neonatal Fc receptor (FcRn), to treat IgG-mediated autoimmune diseases. IMVT-1402 targets conditions including Graves disease, myasthenia gravis, CIDP, rheumatoid arthritis, cutaneous lupus erythematosus, and Sjogrens disease. The company also developed batoclimab (IMVT-1401), a first-generation anti-FcRn antibody. Immunovant operates clinical trials across endocrinology, neurology, rheumatology, and dermatology, leveraging a self-administered YpsoMate autoinjector for drug delivery.","people":[],"products":[{"name":"IMVT-1402","type":"platform","description":"Fully human monoclonal antibody inhibiting FcRn, targeting IgG-mediated autoimmune diseases; delivered via subcutaneous YpsoMate autoinjector."},{"name":"batoclimab (IMVT-1401)","type":"platform","description":"First-generation fully human anti-FcRn monoclonal antibody evaluated in Graves disease, myasthenia gravis, CIDP, and thyroid eye disease."}],"partnerships":[{"partner_name":"HanAll Biopharma Co., Ltd.","partnership_type":"development","description":"Multi-year research collaboration to design and develop highly potent anti-FcRn antibodies including IMVT-1402 and batoclimab.","start_date":null},{"partner_name":"Ypsomed AG","partnership_type":"OEM","description":"Provides the YpsoMate autoinjector device intended as the commercial delivery device for IMVT-1402.","start_date":null}],"affiliations":[],"origin":{"leaf":"ed833eac041d77868dc7d86d3f6a643543eca98b2400f1086eec6c468d8025f4","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"91a889930687f51622edf6d9fe55f215f1c052abda772bdbfad208e8273baeb7","parent":"e0b1f4436f933b5b1c34947814e16845a6b1d2745d20899a6738526aefb3007b","source":"0001764013-25-000092","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":291,"hourly_limit":500,"remaining":209,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}